
Sign up to save your podcasts
Or


Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Scientific American4.2
599599 ratings
Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices

215 Listeners

83 Listeners

52 Listeners

1,398 Listeners

602 Listeners

767 Listeners

942 Listeners

76 Listeners

60 Listeners

548 Listeners

959 Listeners

411 Listeners

822 Listeners

6,459 Listeners

331 Listeners

363 Listeners

379 Listeners

43 Listeners

6,559 Listeners

115 Listeners

516 Listeners